As of April 7, 2022, the total number of COVID-19 cases in Singapore amounted to around 1.1 million. There has been a decrease in daily cases in Singapore this week, though the number is still expected to rise largely due to the highly-contagious Omicron variant.

Overcoming the COVID-19 pandemic Singapore was one of the few countries worldwide that had managed to successfully control the spread of COVID-19. This was done through imposing a strict lockdown period during the beginning of the pandemic in 2020, introducing and enforcing hygiene and social-distancing rules, and effective contact tracing, among others. The measures in place had the intended impact, as the number of daily recorded cases have decreased to manageable levels. Furthermore, community transmission has been reduced to just several cases a week; the majority of the daily new cases of COVID-19 recorded were from overseas arrivals.

Recovering from the economic impact of COVID-19 The closure of businesses, compounded by the global restrictions on movement, had had an adverse effect on its economy. Singapore went through its worse recession on record, while the resident unemployment rate increased. However, with restrictions in the country easing, economists have raised their forecasts for economic growth in Singapore for 2021.

Singapore is currently one out of more than 200 countries and territories battling the novel coronavirus. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

Projected time to peak infection, duration of infection, cumulative infection, proportion infected and total deaths.

Context

From World Health Organization - On 31 December 2019, WHO was alerted to several cases of pneumonia in Wuhan City, Hubei Province of China. The virus did not match any other known virus. This raised concern because when a virus is new, we do not know how it affects people.

So daily level information on the affected people can give some interesting insights when it is made available to the broader data science community.

Johns Hopkins University has made an excellent dashboard using the affected cases data. Data is extracted from the google sheets associated and made available here.

Edited: Now data is available as csv files in the Johns Hopkins Github repository. Please refer to the github repository for the Terms of Use details. Uploading it here for using it in Kaggle kernels and getting insights from the broader DS community.

Content

2019 Novel Coronavirus (2019-nCoV) is a virus (more specifically, a coronavirus) identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China. Early on, many of the patients in the outbreak in Wuhan, China reportedly had some link to a large seafood and animal market, suggesting animal-to-person spread. However, a growing number of patients reportedly have not had exposure to animal markets, indicating person-to-person spread is occurring. At this time, it’s unclear how easily or sustainably this virus is spreading between people - CDC

This dataset has daily level information on the number of affected cases, deaths and recovery from 2019 novel coronavirus. Please note that this is a time series data and so the number of cases on any given day is the cumulative number.

The data is available from 22 Jan, 2020.

Column Description

Main file in this dataset is covid_19_data.csv and the detailed descriptions are below.

covid_19_data.csv

• Sno - Serial number
• ObservationDate - Date of the observation in MM/DD/YYYY
• Province/State - Province or state of the observation (Could be empty when missing)
• Country/Region - Country of observation
• Last Update - Time in UTC at which the row is updated for the given province or country. (Not standardised and so please clean before using it)
• Confirmed - Cumulative number of confirmed cases till that date
• Deaths - Cumulative number of of deaths till that date
• Recovered - Cumulative number of recovered cases till that date

Apart from that these two files have individual level information

COVID_open_line_list_data.csv This file is originally obtained from this link

COVID19_line_list_data.csv This files is originally obtained from this link

Country level datasets If you are interested in knowing country level data, please refer to the following Kaggle datasets: South Korea - https://www.kaggle.com/kimjihoo/coronavirusdataset Italy -
https://www.kaggle.com/sudalairajkumar/covid19-in-italy

Acknowledgements

• Johns Hopkins University for making the data available for educational and academic research purposes
• MoBS lab - https://www.mobs-lab.org/2019ncov.html World Health Organization (WHO): https://www.who.int/
• DXY.cn. Pneumonia. 2020. http://3g.dxy.cn/newh5/view/pneumonia.
• BNO News: https://bnonews.com/index.php/2020/02/the-latest-coronavirus-cases/
• National Health Commission of the People’s Republic of China (NHC): http://www.nhc.gov.cn/xcs/yqtb/list_gzbd.shtml
• China CDC (CCDC): http://weekly.chinacdc.cn/news/TrackingtheEpidemic.htm
• Hong Kong Department of Health: https://www.chp.gov.hk/en/features/102465.html
• Macau Government: https://www.ssm.gov.mo/portal/ Taiwan CDC: https://sites.google.com/cdc.gov.tw/2019ncov/taiwan?authuser=0
• US CDC: https://www.cdc.gov/coronavirus/2019-ncov/index.html
• Government of Canada: https://www.canada.ca/en/public-health/services/diseases/coronavirus.html
• Australia Government Department of Health: https://www.health.gov.au/news/coronavirus-update-at-a-glance
• European Centre for Disease Prevention and Control (ECDC): https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases
• Ministry of Health Singapore (MOH): https://www.moh.gov.sg/covid-19
• Italy Ministry of Health: http://www.salute.gov.it/nuovocoronavirus

Inspiration

Some useful insi...

Model inputs (parameters with * were included in the sensitivity analysis and varied ±25%).

The timing of the public health social measures implemented in response to COVID-19 in different locations/ countries including mainland China, Hong Kong, Taiwan, South Korea, Singapore, Japan, Italy, Germany, the United Kingdom (UK), and the United States of America (USA) specifically during 2020. These PHSMs are classified into case-based, community-wide, and travel-based control measures

BackgroundBorder control mitigates local infections but bears a heavy economic cost, especially for tourism-reliant countries. While studies have supported the efficacy of border control in suppressing cross-border transmission, the trade-off between costs from imported and secondary cases and from lost economic activities has not been studied. This case study of Singapore during the COVID-19 pandemic aims to understand the impacts of varying quarantine length and testing strategies on the economy and health system. Additionally, we explored the impact of permitting unvaccinated travelers to address emerging equity concerns. We assumed that community transmission is stable and vaccination rates are high enough that inbound travelers are not dissuaded from traveling.MethodsThe number of travelers was predicted considering that longer quarantine reduces willingness to travel. A micro-simulation model predicted the number of COVID-19 cases among travelers, the resultant secondary cases, and the probability of being symptomatic in each group. The incremental net monetary benefit (INB) of Singapore was quantified under each border-opening policy compared to pre-opening status, based on tourism receipts, cost/profit from testing and quarantine, and cost and health loss due to COVID-19 cases.ResultsCompared to polymerase chain reaction (PCR), rapid antigen test (ART) detects fewer imported cases but results in fewer secondary cases. Longer quarantine results in fewer cases but lower INB due to reduced tourism receipts. Assuming the proportion of unvaccinated travelers is small (8% locally and 24% globally), allowing unvaccinated travelers will accrue higher INB without exceeding the intensive care unit (ICU) capacity. The highest monthly INB from all travelers is $2,236.24 m, with 46.69 ICU cases per month, achieved with ARTs at pre-departure and on arrival without quarantine. The optimal policy in terms of highest INB is robust under changes to various model assumptions. Among all cost-benefit components, the top driver for INB is tourism receipts.ConclusionsWith high vaccination rates locally and globally alongside stable community transmission, opening borders to travelers regardless of vaccination status will increase economic growth in the destination country. The caseloads remain manageable without exceeding ICU capacity, and costs of cases are offset by the economic value generated from travelers.